Measuring in vivo tumor pHe with CEST-FISP MRI

Magnetic Resonance in Medicine

Volumn 67, Issue 3, 2012, Pages 760-768

  Sheth, Vipul R ^a   Li, Yuguo ^b   Chen, Liu Qi ^c   Howison, Christine M ^d   Flask, Chris A ^a,b   Pagel, Mark D ^c,e,f  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e University of Arizona   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

Author keywords

biophysics; contrast; contrast agents; molecular imaging; technical research; technique development

Indexed keywords

BIOPHYSICS; CHEMICAL DETECTION; FILTRATION; MAGNETIC FIELD EFFECTS; MAGNETIC RESONANCE IMAGING; MEDIAN FILTERS; MOLECULAR IMAGING; MUSCLE; TUMORS;

CHEMICAL EXCHANGE SATURATION TRANSFER; CONTRAST; CONTRAST AGENT; MAGNETIC FIELD STRENGTHS; MRI CONTRAST AGENTS; PARAMAGNETIC CHEMICAL-EXCHANGE-SATURATION- TRANSFERS; TECHNICAL RESEARCH; TECHNIQUE DEVELOPMENT;

PH EFFECTS;

CONTRAST MEDIUM; UNCLASSIFIED DRUG; YB DO3A OAA;

ACCURACY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL PROTOCOL; FEMALE; IN VIVO STUDY; LEG MUSCLE; MAGNETIC FIELD; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PH MEASUREMENT; SENSITIVITY ANALYSIS; TUMOR;

EID: 84857365037     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.23038     Document Type: Article

References (41)

1. Gillies RJ, Gatenby RA,. Hypoxia and adaptive landscapes in the evolution of carcinogenesis. Cancer Metastasis Rev 2007; 26: 311-317. (Pubitemid 47101668)
2. Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, Gillies RJ,. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res 2006; 66: 5216-5223. (Pubitemid 43844945)
3. Cairns R, Papandreou I, Denko N,. Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 2006; 4: 61-70.
4. Gatenby RA, Gilies RJ,. A microenvironmental model of carcinogenesis. Nat Rev Cancer 2008; 8: 56-61.
5. Iessi E, Marino ML, Lozupone F, Fais S, De Milito A,. Tumor acidity and malignancy: novel aspects in the design of anti-tumor therapy. Cancer Ther 2008; 6: 55-66.
6. Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ,. Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 2009; 69: 2260-2268.
7. Raghunand N, He X, van Sluis R, Mahoney B, Baggett B, Taylor CW, Paine-Murrieta G, Roe D, Bhujwalla ZM, Gillies RJ,. Enhancement of chemotherapy by manipulation of tumor pH. Br J Cancer 1999; 80: 1005-1011.
8. Raghunand N, Mahoney BP, Gillies RJ,. Tumor acidity, ion trapping, and chemotherapeutics. II. pH-Dependent partition coefficients predict importance of ion trapping on pharmacokinetics of weakly basic chemotherapeutic agents. Biochem Pharmacol 2003; 66: 1219-1229. (Pubitemid 37130297)
9. Silva AS, Yunes JA, Gillies RJ, Gatenby RA,. The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Res 2009; 69: 2677-2684.
10. Martin NK, Gaffney EA, Gatenby RA, Gillies RJ, Robey IF, PK Maini,. A mathematical model of tumour and blood pHe regulation: the HCO3-/CO2 buffering system. Math Biosci 2011; 230: 1-11.
11. Gillies RJ, Ragunand N, Garcia-Martin ML, Gatenby RA,. pH Imaging. A review of pH measurement methods and applications in cancers. IEEE Eng Med Biol Mag 2004; 23: 57-64.
12. Gallagher FA, Kettunen MI, Day SE, Hu DE, Ardenkjaer-Larsen JH, Zandt R, Jensen PR, Karlsson M, Golman K, Lerche MH, Brindle KM,. Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate. Nature 2008; 453: 940-943. (Pubitemid 351832568)
13. Raghunand N, Howison C, Sherry AD, Zhang S, Gillies RJ,. Renal and systemic pH imaging by contrast-enhanced MRI. Magn Reson Med 2003; 49: 249-257. (Pubitemid 36159861)
14. Garcia-Martin ML, Martinez GV, Raghunand N, Sherry AD, Zhang S, Gillies RJ,. High resolution pHe imaging of rat glioma using pH-dependent relaxivity. Magn Reson Med 2006; 55: 309-315. (Pubitemid 43238099)
15. Martinez GV, Zhang X, Garcia-Martin ML, Morse DL, Woods M, Sherry AD, Gillies RJ,. Imaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agents. NMR Biomed, in press.
16. Aime S, Barge A, Delli Castelli D, Fedeli F, Mortillaro A, Nielsen FU, Terreno E,. Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn Reson Med 2002; 47: 639-648. (Pubitemid 34263776)
17. Liu G, Ali M, Yoo B, Griswold MA, Tkach JA, Pagel MD,. PARACEST MRI with improved temporal resolution. Magn Reson Med 2009; 61: 399-408.
18. Aime S, Delli Castelli D, Terreno E,. Novel pH-reporter MRI contrast agents. Angew Chem 2002; 114: 4510-4512.
19. Liu G, Lu Y, Pagel MD,. Design and characterization of new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide. Magn Reson Med 2007; 58: 1249-1256. (Pubitemid 350234212)
20. Li Y, Sheth VR, Liu G, Pagel MD,. A self-calibrating PARACEST MRI contrast agent that detects esterase enzyme activity. Contrast Media Mol imaging, in press.
21. Liu G, Li Y, Sheth VR, Pagel MD,. Imaging in vivo extracellular pH with a single PARACEST MRI contrast agent. Mol Imaging, in press.
22. Sun PZ, Benner T, Kumar A, Sorensen AG,. Investigation of optimizing and translating pH-sensitive pulsed-chemical exchange saturation transfer (CEST) imaging to a 3T clinical scanner. Magn Reson Med 2008; 60: 834-841.
23. Shah T, Lu L, Dell KM, Pagel MD, Griswold MA, Flask CA,. CEST-FISP: a novel technique for rapid chemical exchange saturation transfer MRI at 7 T. Magn Reson Med 2011; 65: 432-437.
24. Kim M, Gillen J, Landman BA, Zhou J, van Zijl PCM,. Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med 2009; 61: 1441-1450.
25. Stancanello J, Terreno E, Delli Castelli D, Cabella C, Uggeri F, Aime S,. Development and validation of a smoothing-splines-based correction method for improving the analysis of CEST-MR images. Contrast Media Mol Imaging 2008; 3: 136-149.
26. Morrison C, Stanisz G, Henkelman RM,. Modeling magnetization transfer for biological-like systems using a semi-solid pool with a super-Lorentzian line shape and dipolar reservoir. J Magn Reson Series B 1995; 108: 103-113.
27. Chan RH, Ho C-W, Nikolova M,. Salt-and-pepper noise removal by median-type noise detectors and detail-preserving regularization. IEEE Trans Image Process 2005; 14: 1479-1485. (Pubitemid 41623079)
28. Woessner DE, Zhang S, Merritt ME, Sherry AD,. Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI. Magn Reson Med 2005; 53: 790-799. (Pubitemid 40478426)
29. Zhou J, Wilson DA, Sun PZ, Klaus JA, van Zijl PCM,. Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments. Magn Reson Med 2004; 51: 945-952. (Pubitemid 38580606)
30. Tweedle MF, Wedeking P, Kumar K,. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats. Invest Radiol 1995; 30: 372-380.
31. Yankeelov TE, Gore JC,. Dynamic contrast enhanced magnetic resonance imaging in oncology: theory, data acquisition, analysis, and examples. Curr Med Imaging Rev 2007; 3: 91-107. (Pubitemid 46773870)
32. Parmelee DJ, Walovitch RC, Ouellet HS, Lauffer RB,. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 1997; 32: 741-747. (Pubitemid 28053505)
33. Li AX, Hudson RHE, Barrett JW, Jones CK, Pasternak SH, Bartha R,. Four-pool modeling of proton exchange processes in biological systems in the presence of MRI-paramagnetic chemical exchange saturation transfer (PARACEST) agents. Magn Reson Med 2008; 60: 1197-1206.
34. Winter PM, Cai K, Chen J, Adair CR, Kiefer GE, Athey PS, Gaffney PJ, Buff CE, Robertson JD, Caruthers SD, Wickline SA, Lanza GM,. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin. Magn Reson Med 2006; 56: 1384-1388. (Pubitemid 44865324)
35. Pikkemaat JA, Wegh RT, Lamerichs R, van de Molengraaf RA, Langereis S, Burdinski D, Raymond AYF, Janssen HM, de Waal BFM, Willard NP, Meijer EW, Gruell H,. Dendritic PARACEST contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging 2007; 2: 229-239. (Pubitemid 351166059)
36. Vasalatiy O, Gerard RD, Zhao P, Sun X, Sherry AD,. Labeling of adenovirus particles with PARACEST agents. Bioconjug Chem 2008; 19: 598-606. (Pubitemid 351431390)
37. Ali MM, Yoo B, Pagel MD,. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI. Molec Pharm 2009; 6: 1409-1416.
38. Terreno E, Stancanello J, Longo D, Delli Castelli D, Luciano M, Sanders HMHF, Kok M, Uggeri F, Aime S,. Methods for an improved detection of the MRI-CEST effect. Contrast Media Mol Imaging 2009; 4: 237-247.
39. Wu Y, Zhao P, Kiefer GE, Sherry AD,. Multifunctional polymeric scaffolds for enhancement of PARACEST contrast sensitivity and performance: effects of random copolymer variations. Macromolecules 2010; 43: 6616-6624.
40. Sherry AD, Caravan P, Lenkinski RE,. Primer on gadolinium chemistry. J Magn Reson Imaging 2009; 30: 1240-1248.
41. Longo DL, Dastrà W, Digilio G, Keupp J, Langereis S, Lanzardo S, Simone Prestigio S, Steinbach O, Terreno E, Uggeri F, Aime S,. Iopamidol as a responsive MRI-chemical exchange saturation transfer contrast agent for pH mapping of kidneys: in vivo studies in mice at 7 T. Magn Reson Med 2011; 65: 202-211.